111 Capital’s Qiagen QGEN Stock Holding History

111 Capital’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,967	Closed	-$776K	–	428
2025 Q4	$776K	Buy	+16,967	New	+$785K	0.17%	103
2025 Q3	–	Sell	-47,321	Closed	-$2.28M	–	647
2025 Q2	$2.28M	Buy	+47,321	New	+$2.06M	0.39%	45

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

111 Capital's QGEN Position: Q1 2026 in Review

111 Capital sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 16,967 shares — an estimated $776K sold.

111 Capital first reported a position in QGEN in Q2 2025 and held it in 2 quarters. The position peaked at $2.28M in Q2 2025. 346 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

111 Capital reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
111 Capital sold 16,967 Qiagen shares in Q1 2026, an estimated $776K.
111 Capital first reported a position in Qiagen in Q2 2025 and held it in 2 quarters.
111 Capital's Qiagen position peaked at $2.28M in Q2 2025.
346 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on 111 Capital's 13F filing for Q1 2026, filed 11 May 2026.